Bio Pharma Dive

AUGUST 26, 2022

The pharma company terminated a collaboration that could’ve netted the biotech about $350 million. It’s the latest in a string of recent setbacks for microbiome drug developers.

Pharma Companies 242

Pharma Companies Drugs Development 242

Pharmaceutical Technology

OCTOBER 26, 2023

Experts discuss how pharma companies need to consider patient centricity earlier in their development plans.

Pharma Companies 130

Pharma Companies Development Drugs 130

Bio Pharma Dive

JULY 24, 2023

The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.

Pharma Companies 246

Pharma Companies Research Medicine Drugs 246

Bio Pharma Dive

MARCH 1, 2023

The pharma company, along with its diabetes drug rivals Novo Nordisk and Sanofi, has long been under pressure over the high cost of insulin — scrutiny that has recently ramped up in the U.S.

Insulin 273

Insulin Pharma Companies Drugs 273

Bio Pharma Dive

OCTOBER 28, 2022

Disappointing study results have led the French pharma company to take a $1.6 billion impairment charge and plan new early-stage trials for a drug executives once called a potential “foundation” for newer immunotherapy combinations.

Pharma Companies 183

Pharma Companies Drugs Trials 183

STAT News

OCTOBER 25, 2022

Over the course of the pandemic, online prescribing has been embraced as a powerful tool in health care — not just by patients, but by a growing number of drug companies. It’s a powerful mashup of telehealth and direct-to-consumer advertising that has inspired increasing investment from drugmakers.

Pharma Companies 122

Pharma Companies Drugs 122

Bio Pharma Dive

NOVEMBER 13, 2020

An alliance with BeyondSpring spinout Seed Therapeutics makes Eli Lilly the latest pharma company to dive into the fast-emerging drug research field.

Protein 237

Protein Pharma Companies Drugs Research 237

Pharmaceutical Technology

JULY 17, 2024

As US China trade relations are set to be impacted by the BIOSECURE Act, pharma companies exploring CDMOs outside China may need to contend with increased drug development and manufacturing costs.

Development 147

Development Pharma Companies Drugs Manufacturing 147

World of DTC Marketing

FEBRUARY 21, 2022

Experts across the board are predicting demand for antiviral drugs will rapidly outpace supply. Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). Reportedly, the cost of production for molnupiravir stands at about $17.74.

Regulation 218

Regulation Drugs Bioequivalency Vaccine 218

World of DTC Marketing

OCTOBER 1, 2020

WHAT NOW: The idea that most pharma companies are here to serve patients is a canard. Pharma CEO’s serve themselves with big salaries tied to drug prices and keeping drugs from coming off patent. “Did the drug get substantially more effective in that time? Did cancer patients need fewer pills?”

Drugs 181

Drugs Pharma Companies Branding Sales 181

World of DTC Marketing

FEBRUARY 25, 2022

billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp, which the drugmaker bought in 2019. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec.

Drugs 216

Drugs Sales Pharma Companies Manufacturing 216

Bio Pharma Dive

JUNE 16, 2022

The German pharma company has secured an option to acquire Trutino Biosciences, two years after inking a research collaboration with the San Diego drug developer.

Pharma Companies 210

Pharma Companies Development Drugs Research 210

Bio Pharma Dive

MARCH 15, 2023

Under the Inflation Reduction Act, pharma companies owe rebates to Medicare for price increases that exceed inflation. But they won’t need to pay until 2025.

Pharma Companies 183

Pharma Companies Drugs 183

Bio Pharma Dive

APRIL 7, 2022

The pharma company adds experimental RSV treatments to its pipeline through the deal, which is worth up to $525 million.

Pharma Companies 171

Pharma Companies Research Drugs 171

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. They relied so much on a new drug that they tried to market a product with bad science behind it.

Pharma Companies 210

Pharma Companies Drugs Marketing Production 210

Bio Pharma Dive

JULY 18, 2023

The pharma company, which will soon split off its generic drug unit, plans to repurchase up to $15 billion of its shares through the end of 2025.

Generic Drugs 130

Generic Drugs Sales Pharma Companies Drugs 130

Bio Pharma Dive

JULY 29, 2024

The pharma company will pay up to $1.3 billion to acquire San Diego-based Nerio and its research into novel immune checkpoint inhibitors.

Pharma Companies 148

Pharma Companies Drugs Research 148

Pharmaceutical Technology

OCTOBER 2, 2023

Many pharma companies argue that Medicare’s gross spending disregards rebates, discounts and fees paid to prescription drug insurance plans.

Pharma Companies 130

Pharma Companies Drugs Marketing 130

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 8, 2024

The Drugs Technical Advisory Board (DTAB) has suggested to the ministry of health and family welfare (MoHFW) to write to the ministry of corporate affairs to mandate the pharma companies to spend almost one per cent of their net profit for providing free medicines in medicine banks as part of the Corporate Social Responsibility (CSR). […]

Medicine 185

Medicine Pharma Companies Drugs Clinical Trials 185

Pharmaceutical Technology

MARCH 6, 2023

Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. It will also establish cGMP manufacturing of a drug product which will be utilised in future clinical trials.

Manufacturing 264

Manufacturing Clinical Trials Clinical Trials Production 264

STAT News

JANUARY 6, 2023

Continuous manufacturing produces a drug product from start to finish through a nonstop, integrated assembly. In contrast, most of the pharmaceutical industry currently uses batch manufacturing, which involves producing a finished drug product through multiple distinct steps in series. I’m talking about continuous manufacturing.

Manufacturing 111

Manufacturing Pharma Companies Production Drugs 111

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 12, 2023

Indian pharma sees immense value in US FDA’s insistence for aluminum content and labelling recommendations for the Small Volume Parenterals Drug Products and Pharmacy Bulk Packages. Pharma companies in the country have increasingly made a shift to nutritional based prescription and over the counter products.

Packaging 188

Packaging Packaging Pharmacy Pharma Companies 188

World of DTC Marketing

DECEMBER 9, 2021

LEAD IN: Pharma budgets are being scrutinized like never before, and DTC/HCP marketers must justify every dollar spent. One top-10 pharma company has created a “market launch metric” team to measure key launch milestones. ” The post Do you have enough money to launch your drug?

Drugs 204

Drugs Branding Marketing Production 204

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 11, 2023

The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharma companies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]

Pharma Companies 186

Pharma Companies Licensing Licensing Sales 186

pharmaphorum

JANUARY 28, 2024

The CHMP has rejected marketing approvals for two drugs from Neuraxpharm and Apellis, but the pharma companies say they will appeal

Drugs 110

Drugs Pharma Companies Marketing 110

Pharmaceutical Technology

JUNE 7, 2024

The US Food and Drug Administration (FDA) has criticised the state of Chinese pharma company Jiangsu Hengrui’s facilities in a newly released 483 form.

Manufacturing 147

Manufacturing Pharma Companies Drugs 147

Pharmaceutical Technology

AUGUST 21, 2024

Pharma companies seeking to commercialise in mRNA can gain a competitive edge by partnering with expert suppliers

Pharma Companies 130

Pharma Companies Development Drugs 130

Bio Pharma Dive

SEPTEMBER 25, 2023

Novartis has made a large investment in targeted radiotherapies, sparking competition from fellow pharma companies and young biotechs.

Pharma Companies 139

Pharma Companies Drugs 139

Outsourcing Pharma

APRIL 19, 2024

revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing. Earlier this week, Charles River Laboratories International, Inc.

Pharma Companies 99

Pharma Companies Development Drugs 99

World of DTC Marketing

MAY 17, 2022

Just 13% of people trust the pharma companies they interact with. If pharma is going to leap to a new era of marketing, they have to get to know their audiences. Some believe that these behaviors won’t translate to prescription drugs, but that would be a mistake. 68% say the interactions feel transactional.

Marketing 214

Marketing Pharma Companies Branding Drugs 214

pharmaphorum

DECEMBER 19, 2023

Big pharma companies like Pfizer are making significant investments in antibody-drug conjugates, a promising class of therapies. This article explores the growing interest and recent developments, including FDA approvals and the potential impact on the pharmaceutical industry.

Antibody 115

Antibody FDA Approval Pharma Companies Drugs 115

World of DTC Marketing

FEBRUARY 7, 2022

At 99% of pharma companies, that's a huge no-no. On top of this, “the company also revealed that the Federal Trade Commission and the Securities and Exchange Commission had opened two new, separate investigations into the troubled biotech. At 99% of pharma companies, that’s a huge no-no.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

Outsourcing Pharma

MAY 23, 2024

A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.

Pharma Companies 78

Pharma Companies Drugs Medicine Development 78

World of DTC Marketing

MARCH 18, 2021

This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. Some patients love the brand of prescription drugs they take because simply “they work” Pharma companies do study brand names, but that’s only about the overall branding of the product.

Branding 180

Branding Pharma Companies Pharma Production Drugs 180

World of DTC Marketing

JANUARY 26, 2022

Further, 62% of HCPs said that the most significant area where pharma representatives can add value is, by understanding the needs of HCPs and sharing only relevant content with them to make the interactions more insightful. At the same time, marketing emails are among the top 5 channels used by pharma companies to engage HCPs.

Marketing 202

Marketing Pharma Companies Production Drugs 202

XTalks

DECEMBER 4, 2024

Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

Pharmaceutical Technology

NOVEMBER 3, 2023

Kronos Bio joins other pharma companies in workforce reductions, cutting 19% of its employees to support clinical development.

Pharma Companies 130

Pharma Companies Clinical Development Drugs Development 130